The current process for CAR T-cell therapy can take weeks, with patients’ T cells removed, sent to a laboratory, enhanced with a chimeric antigen receptor (CAR), sent back to the hospital and infused back into the patients.
Matthias Stephan, MD, PhD, an Alliance for Cancer Gene Therapy Research Fellow, is creating a way to speed up the process using injected mRNA to engineer T cells into CAR T cells as they circulate within the body.
Learn how this method may benefit patients.